Preferred Name |
cerivastatin |
|
Synonyms |
6-Heptenoic acid, 7-(4-(4-fluorophenyl)-5-(methoxymethyl)-2,6-bis(1-methylethyl)-3-pyridinyl)-3,5-dihydroxy-, monosodium salt, (S-(R*,S*-(E)))- Certa Baycol Kazak rivastatin cerivastatin sodium Bay w 6228 Lipobay 7-(4-(4-fluorophenyl)-2,6-diisopropyl-5-(methoxymethyl)pyrid-3-yl)-3,5-dihydroxy-6-heptenoate sodium salt |
|
ID |
http://purl.bioontology.org/ontology/MESH/C086276 |
|
altLabel |
6-Heptenoic acid, 7-(4-(4-fluorophenyl)-5-(methoxymethyl)-2,6-bis(1-methylethyl)-3-pyridinyl)-3,5-dihydroxy-, monosodium salt, (S-(R*,S*-(E)))- Certa Baycol Kazak rivastatin cerivastatin sodium Bay w 6228 Lipobay 7-(4-(4-fluorophenyl)-2,6-diisopropyl-5-(methoxymethyl)pyrid-3-yl)-3,5-dihydroxy-6-heptenoate sodium salt |
|
cui |
C1530129 C0252746 C0724549 C0718827 C1174744 C0528023 |
|
HM |
D011725 |
|
Inverse of RB |
AM91H2KS67 |
|
isa | ||
LT |
TRD |
|
Mapped to | ||
MDA |
19940413 |
|
MeSH Frequency |
530 |
|
MMR |
20141022 |
|
notation |
C086276 |
|
PA |
D019161 |
|
prefLabel |
cerivastatin |
|
SC |
1 |
|
Scope Statement |
cerivastatin is the ((E)-(+))-isomer; structure given in first source |
|
SRC |
J Pharm Biomed Anal 1993 Nov-Dec;11(11-12):1269-75 |
|
TERMUI |
T461013 T624540 T258734 T461012 T258735 T258733 T624538 T420190 T534913 T258732 |
|
TH |
US NLM (2004) FDA SRS (2013) NLM (2001) NLM (1994) INN (19XX) NLM (2003) AU IE |
|
tui |
T109 T121 |